SCHEDULE: FMR LLC Discloses 5.6% Stake in Evolent Health
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 5.6% of Evolent Health Inc.'s Class A Common Stock as of June 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson reported beneficial ownership of 6,623,230.93 shares of Evolent Health Inc.'s Class A Common Stock.
- This represents 5.6% of the outstanding Class A Common Stock.
- The ownership was reported as of June 30, 2025, the date the ownership threshold was crossed.
- FMR LLC holds sole voting power over 6,594,824.92 shares and sole dispositive power over 6,623,230.93 shares.
- Abigail P. Johnson holds sole dispositive power over 6,623,230.93 shares.
- The filing was made under Rule 13d-1(b), certifying that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- Fidelity Management & Research Company LLC is identified as an entity within FMR LLC that beneficially owns 5% or greater of the outstanding shares.
Sentiment
Score: 5
Explanation: Neutral. This is a routine disclosure of beneficial ownership by an institutional investor, not indicative of positive or negative company performance or operational changes.
Industry Context
This filing indicates a significant institutional investment in Evolent Health Inc., a company operating in the healthcare technology sector. Such disclosures are common for large asset managers like FMR LLC as they cross ownership thresholds, reflecting their investment strategies within various industries.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Shareholder Voting Agreement (FMR LLC Internal) | Members of the Johnson family, including Abigail P. Johnson, who are predominant owners of Series B voting common shares of FMR LLC (representing 49% of voting power), have entered into a shareholders' voting agreement. This agreement dictates that all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares, potentially forming a controlling group with respect to FMR LLC under the Investment Company Act of 1940. | N/A | This detail pertains to the internal governance and control structure of FMR LLC, the reporting entity, and clarifies how the reported shares are controlled. It does not directly impact Evolent Health Inc.'s corporate governance. |
Stakeholder Impact
- Shareholders: Increased institutional ownership by a major asset manager like FMR LLC can be viewed positively, signaling confidence in the company's long-term prospects and potentially attracting further institutional interest.
Key Dates
| Date | Description |
|---|---|
| 2023-05-23 | Effective date of Power of Attorney for Richard Bourgelas, authorizing him to sign on behalf of FMR LLC and Abigail P. Johnson. |
| 2023-08-08 | Date of previous Schedule 13G filing by FMR LLC (accession number -23-002397) where the Power of Attorney is incorporated by reference. |
| 2025-06-30 | Date of event which requires filing of this statement, indicating when the beneficial ownership threshold was met. |
| 2025-08-05 | Date of the joint filing agreement and signature date for FMR LLC and Abigail P. Johnson on this Schedule 13G. |
Keywords
Evolent Health Inc, FMR LLC, Abigail P. Johnson, Class A Common Stock, Beneficial Ownership, Institutional Investor, SEC Filing, Schedule 13G, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.